Eris Lifesciences Pays Interest on Outstanding Non-convertible Debentures
Eris Lifesciences Ltd has completed the routine interest servicing against its outstanding non-convertible debentures (NCDs). The company made these payments across two series of NCDs on June 8, 2026.The interest payment relates to a record date of May 24, 2026, for both tranches.
Interest Payment Details by Debenture Series
Eris Lifesciences provided comprehensive details regarding the servicing of interest payments for its outstanding debentures. The transactions are detailed in the following tables:Interest Payments on NCD (ISIN INE406M08029)
| Particulars | Amount (Rs. In crore) |
|---|---|
| Issue Size | 625 |
| Interest Amount Due | 54.56 |
| Gross Interest Paid | 54.56 |
| Tax Deducted at Source (TDS) | 1.98 |
| Net Interest Paid | 52.58 |
Interest Payments on NCD (ISIN INE406M08011)
| Particulars | Amount (Rs. In crore) |
|---|---|
| Issue Size | 625 |
| Interest Amount Due | 54.56 |
| Gross Interest Paid | 54.56 |
| Tax Deducted at Source (TDS) | 1.15 |
| Net Interest Paid | 53.41 |
Summary of Interest Servicing
The payment details confirm the status of interest servicing for both debenture series on the due date of June 8, 2026. These payments constitute the company's routine interest commitment against its outstanding debt obligations.ERIS Stock Price Movement
Eris Lifesciences Limited settled today after gaining 0.48%, closing at ₹1371.70, reflecting modest upward pressure in the stock. The company saw active trading, with the stock changing hands in a volume of 56,947 shares today.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.